Several tumor markers, such as ɑ-fetoprotein (AFP), prostate specific antigen (PSA), and cancer antigen125 (CA125), have been proven to be highly sensitive and effective for the screening of liver, prostate, and ovarian cancers [50]. This evidence concerns the gene KLK3 and ovarian cancer.